T9197
Tissue Inhibitor of Metalloproteinase-3 human
>95% (SDS-PAGE), recombinant, expressed in BHK cells, buffered aqueous solution
Synonym(s):
TIMP-3
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
MDL number:
UNSPSC Code:
12352200
recombinant
expressed in BHK cells
Assay
>95% (SDS-PAGE)
form
buffered aqueous solution
mol wt
glycosylated form ~30 kDa
~23 kDa (unglycosylated form)
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... TIMP3(7078)
Looking for similar products? Visit Product Comparison Guide
Biochem/physiol Actions
The TIMPs are endogenous inhibitors of the matrix metalloproteinases (MMPs). TIMP-3 inhibits ADAM-17 (TACE) at nanomolar concentrations and also inhibits other metalloproteinases (sheddases) that mediate the shedding of soluble receptors and other proteins from the surface of cells.
Physical form
Supplied in acitve form, in 10 mM MES, pH 5.0, 100 mM sodium chloride, 0.02% Brij-35 and 50% glycerol.
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
M L Sulis et al.
Leukemia, 25(10), 1564-1569 (2011-06-01)
Oncogenic mutations in NOTCH1 are present in over 50% of T-cell lymphoblastic leukemias (T-ALLs). Activation of NOTCH1 requires a double proteolytic processing in the extracellular region of the receptor (S2) and in the transmembrane domain (S3). Currently, anti-NOTCH1 therapies based
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service